401 followers
👇🏽👇🏽👇🏽
👇🏽👇🏽👇🏽
RT @FrontImmunol: New Research: PD-1 inhibitors-based second-line therapy for metastatic gastric cancer: Background Metastatic gastric can…
New Research: PD-1 inhibitors-based second-line therapy for metastatic gastric cancer: Background Metastatic gastric cancer (MGC) patients with progression on first-line treatment still have poor outcomes on chemotherapy. The KEYNOTE-061… #immunology http
PD-1 inhibitors-based second-line therapy for metastatic gastric cancer https://t.co/1x6NvEa6lN